Contact lenses for antifungal ocular drug delivery: a review

Introduction: Fungal keratitis, a potentially blinding disease, has been difficult to treat due to the limited number of approved antifungal drugs and the taxing dosing regimen. Thus, the development of a contact lens (CL) as an antifungal drug delivery platform has the potential to improve the treatment of fungal keratitis. A CL can serve as a drug reservoir to continuously release drugs to the cornea, while limiting drug loss through tears, blinking, drainage and non-specific absorption. Areas covered: This review will provide a summary of currently available methods for delivering antifungal drugs from commercial and model CLs, including vitamin E coating, impregnated drug films, cyclodextrin-functionalized hydrogels, polyelectrolyte hydrogels and molecular imprinting. This review will also highlight some of the main factors that influence antifungal drug delivery with CLs. Expert opinion: Several novel CL materials have been developed, capable of extended drug release profiles with a wide range of antifungal drugs lasting from 8 h to as long as 21 days. However, there are factors, such as first-order release kinetics, effectiveness of continuous drug release, microbial resistance, ocular toxicity and potential complications from inserting a CL in an infected eye, that still need to be addressed before commercial applications can be realized.

[1]  D. O'day Selection of Appropriate Antifungal Therapy , 1987, Cornea.

[2]  M. Mannis,et al.  Practice Patterns in the Management of Fungal Corneal Ulcers , 2009, Cornea.

[3]  N. Peppas,et al.  Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. II. Diffusion and release studies , 1997 .

[4]  A. Yakar,et al.  Controlled release of antifungal drug terbinafine hydrochloride from poly(N-vinyl 2-pyrrolidone/itaconic acid) hydrogels. , 2001, International journal of pharmaceutics.

[5]  P. Thomas Current Perspectives on Ophthalmic Mycoses , 2003, Clinical Microbiology Reviews.

[6]  S. Tuft,et al.  Fungal Keratitis in London: Microbiological and Clinical Evaluation , 2007, Cornea.

[7]  Xiaodong Fan,et al.  Release of chlorambucil from poly(N-isopropylacrylamide) hydrogels with beta-cyclodextrin moieties. , 2004, Macromolecular bioscience.

[8]  C. Karlgard,et al.  Survey of Bandage Lens Use in North America, October–December 2002 , 2004, Eye & contact lens.

[9]  Lyndon Jones,et al.  Uptake and Release of Ciprofloxacin-HCl From Conventional and Silicone Hydrogel Contact Lens Materials , 2008, Eye & contact lens.

[10]  C. Karlgard,et al.  In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. , 2003, International journal of pharmaceutics.

[11]  G. Rao,et al.  Microbial Keratitis in Prospective Studies of Extended Wear With Disposable Hydrogel Contact Lenses , 2005, Cornea.

[12]  H. Riezman,et al.  Natamycin Blocks Fungal Growth by Binding Specifically to Ergosterol without Permeabilizing the Membrane* , 2008, Journal of Biological Chemistry.

[13]  Silbert Ja A review of therapeutic agents and contact lens wear , 1996 .

[14]  R. Ramakrishnan,et al.  Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. , 2003, Indian journal of ophthalmology.

[15]  Ping I. Lee,et al.  Effect of Loading on Swelling-Controlled Drug Release from Hydrophobic Polyelectrolyte Gel Beads , 1992, Pharmaceutical Research.

[16]  C. Phan,et al.  In Vitro Uptake and Release of Natamycin From Conventional and Silicone Hydrogel Contact Lens Materials , 2013, Eye & contact lens.

[17]  Shin Horikawa,et al.  Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Teruo Okano,et al.  Hydrogels: Swelling, Drug Loading, and Release , 1992, Pharmaceutical Research.

[19]  Abdulrhman Akasha,et al.  Cyclodextrins and their Pharmaceutical Applications , 2014 .

[20]  Anuj Chauhan,et al.  Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. , 2010, Biomaterials.

[21]  Xiaodong Fan,et al.  A cyclodextrin microgel for controlled release driven by inclusion effects , 2004 .

[22]  T. Coenye,et al.  Functionalization of acrylic hydrogels with alpha-, beta- or gamma-cyclodextrin modulates protein adsorption and antifungal delivery. , 2010, Acta biomaterialia.

[23]  Anuj Chauhan,et al.  Ophthalmic drug delivery through contact lenses. , 2004, Investigative ophthalmology & visual science.

[24]  R. Narayanan,et al.  Efficacy of continuous wear PureVision contact lenses for therapeutic use. , 2004, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[25]  L. Jones,et al.  Ciprofloxacin Interaction with Silicon-Based and Conventional Hydrogel Contact Lenses , 2003, Eye & contact lens.

[26]  Susan Budavari,et al.  The Merck index : an encyclopedia of chemicals, drugs, and biologicals , 1983 .

[27]  F. Gu,et al.  In vitro uptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials , 2014, Journal of biomaterials science. Polymer edition.

[28]  F. Otero-Espinar,et al.  Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability. , 2006, International journal of pharmaceutics.

[29]  J. Isasi,et al.  β-Cyclodextrin hydrogels as potential drug delivery systems , 2012 .

[30]  J W Shell,et al.  Pharmacokinetics of topically applied ophthalmic drugs. , 1982, Survey of ophthalmology.

[31]  S. Schallhorn,et al.  Masked comparison of silicone hydrogel lotrafilcon A and etafilcon A extended‐wear bandage contact lenses after photorefractive keratectomy , 2005, Journal of cataract and refractive surgery.

[32]  D. Stevens,et al.  Effect of cyclodextrin on the pharmacology of antifungal oral azoles , 1992, Antimicrobial Agents and Chemotherapy.

[33]  J. L. Gómez-Amoza,et al.  Soft contact lenses capable of sustained delivery of timolol. , 2002, Journal of pharmaceutical sciences.

[34]  T. Kuriakose,et al.  Keratitis due to Cephaliophora irregularis Thaxter. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[35]  G. Fink,et al.  A prototype antifungal contact lens. , 2011, Investigative ophthalmology & visual science.

[36]  T. O'brien THERAPY OF OCULAR FUNGAL INFECTIONS , 1999 .

[37]  J. Silbert A review of therapeutic agents and contact lens wear. , 1996, Journal of the American Optometric Association.

[38]  O. Corrigan,et al.  Effect of drug physicochemical properties on swelling/deswelling kinetics and pulsatile drug release from thermoresponsive poly(N-isopropylacrylamide) hydrogels. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[39]  M. Srinivasan,et al.  Corneal blindness: a global perspective. , 2001, Bulletin of the World Health Organization.

[40]  Susan Budavari,et al.  The merck index an encyclopedia of chemical, drugs, and biologicals , 1989 .

[41]  N. Rajagopalan,et al.  A study of the inclusion complex of amphotericin-B with γ-cyclodextrin , 1986 .

[42]  D. Fonn,et al.  A Review of the Holden–Mertz Criteria for Critical Oxygen Transmission , 2005, Eye & contact lens.

[43]  Loading and Release of a Phospholipid From Contact Lenses , 2011, Optometry and vision science : official publication of the American Academy of Optometry.

[44]  N. Peppas,et al.  Modeling of drug release from swellable polymers. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  J. Avorn,et al.  Treatment for glaucoma: adherence by the elderly. , 1993, American journal of public health.

[46]  L. Subbaraman,et al.  Kinetics of Lysozyme Activity Recovered from Conventional and Silicone Hydrogel Contact Lens Materials , 2010, Journal of biomaterials science. Polymer edition.

[47]  J. Varshousaz,et al.  Cross-linked Poly (vinyl alcohol) Hydrogel : Study of Swelling and Drug Release Behaviour , 2002 .

[48]  K. Ashok,et al.  Cyclodextrins as Drug Carrier Molecule: A Review , 2008 .

[49]  J. Dekker,et al.  Protection of antibiotic pimaricin from oxidation and ultraviolet light by chlorophyllin and other compounds. , 1959, Antibiotics & chemotherapy.

[50]  Deenu Kanjickal,et al.  Improving delivery of hydrophobic drugs from hydrogels through cyclodextrins. , 2005, Journal of biomedical materials research. Part A.

[51]  O. Wichterle,et al.  Hydrophilic Gels for Biological Use , 1960, Nature.

[52]  S. Waheed,et al.  A Unique Case of Cryptococcus laurentii Keratitis Spread by a Rigid Gas Permeable Contact Lens in a Patient with Onychomycosis , 1998, Cornea.

[53]  A. Chauhan,et al.  Drug Delivery by Contact Lens in Spontaneously Glaucomatous Dogs , 2012, Current eye research.

[54]  H. Edelhauser,et al.  Barriers to Glaucoma Drug Delivery , 2008, Journal of glaucoma.

[55]  Shujuan Sun,et al.  In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. , 2008, The Journal of antimicrobial chemotherapy.

[56]  S. Baboota,et al.  Multiple-pulse drug delivery systems: setting a new paradigm for infectious disease therapy. , 2009, Expert opinion on drug delivery.

[57]  C. Alvarez‐Lorenzo,et al.  Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[58]  H. Sheardown,et al.  Acetic and Acrylic Acid Molecular Imprinted Model Silicone Hydrogel Materials for Ciprofloxacin-HCl Delivery , 2012, Materials.

[59]  J. Marcy,et al.  Formation of natamycin:cyclodextrin inclusion complexes and their characterization. , 2003, Journal of agricultural and food chemistry.

[60]  R. Fitzsimons,et al.  Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. , 1986, American journal of ophthalmology.

[61]  K. Johnston,et al.  In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[62]  E. Papas,et al.  Silicone hydrogel contact lenses and the ocular surface. , 2006, The ocular surface.

[63]  I. Kaur,et al.  Development of effective ocular preparations of antifungal agents. , 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[64]  N. Brennan,et al.  A 1-year prospective clinical trial of balafilcon a (PureVision) silicone-hydrogel contact lenses used on a 30-day continuous wear schedule. , 2002, Ophthalmology.

[65]  T. Deutsch,et al.  Topical tetracaine with bandage soft contact lens pain control after photorefractive keratectomy. , 2000, Journal of refractive surgery.

[66]  S. Levy,et al.  The impact of antibiotic use on resistance development and persistence. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[67]  M. Byrne,et al.  Sustained in vivo release from imprinted therapeutic contact lenses. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[68]  Fu-qian Sun,et al.  PVA Hydrogels Containing β-Cyclodextrin for Enhanced Loading and Sustained Release of Ocular Therapeutics , 2010, Journal of biomaterials science. Polymer edition.

[69]  A. Rotchford,et al.  Compliance with timolol treatment in glaucoma , 1998, Eye.

[70]  T. F. Patton,et al.  Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. , 1978, American journal of ophthalmology.

[71]  H. Shore,et al.  A three-year study , 1972 .

[72]  P. Sharma,et al.  Recent Trends in Ocular Drug Delivery: A Short Review , 2011 .

[73]  M. Strømme,et al.  Characterization of the drug release process by investigation of its temperature dependence. , 2004, Journal of pharmaceutical sciences.

[74]  A. Thomas Analysis and assay of polyene antifungal antibiotics. A review. , 1976, The Analyst.

[75]  Y. Ishibashi Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. , 1986, American journal of ophthalmology.

[76]  B. Reddy,et al.  In vitro drug release studies from the polymeric hydrogels based on HEA and HPMA using 4-[(E)-[(3Z)-3-(4-(acryloyloxy)benzylidene)-2-hexylidene]methyl]phenyl acrylate as a crosslinker. , 2005, Biomaterials.

[77]  Ping I. Lee,et al.  Probing the mechanisms of drug release from hydrogels , 1991 .

[78]  R. Beck,et al.  Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses , 1999, European Journal of Clinical Pharmacology.

[79]  J. Ernest Topical antifungal agents. , 1992, Obstetrics and gynecology clinics of North America.

[80]  R. H. Rosa,et al.  The changing spectrum of fungal keratitis in south Florida. , 1994, Ophthalmology.

[81]  L Keay,et al.  Tear exchange under hydrogel contact lenses: methodological considerations. , 2001, Investigative ophthalmology & visual science.

[82]  D. Tan,et al.  Therapeutic use of Bausch & Lomb PureVision contact lenses. , 2001, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.

[83]  Jianhua Wang,et al.  Precorneal and pre- and postlens tear film thickness measured indirectly with optical coherence tomography. , 2003, Investigative ophthalmology & visual science.

[84]  Á. Hernanz,et al.  Terbinafine Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Superficial Mycoses , 1992 .

[85]  R. Langer,et al.  A drug-eluting contact lens. , 2009, Investigative ophthalmology & visual science.

[86]  G. Foulks,et al.  Therapeutic contact lenses: the role of high-Dk lenses. , 2003, Ophthalmology clinics of North America.

[87]  A. Concheiro,et al.  Molecularly imprinted polymers for drug delivery. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[88]  H. V. von Recum,et al.  Cyclodextrin complexation for affinity-based antibiotic delivery. , 2010, Macromolecular bioscience.

[89]  Olof Ramström,et al.  The Emerging Technique of Molecular Imprinting and Its Future Impact on Biotechnology , 1996, Bio/Technology.

[90]  A. Chauhan,et al.  Modeling Ophthalmic Drug Delivery by Soaked Contact Lenses , 2006 .

[91]  C. Radke,et al.  Scalloped Channels Enhance Tear Mixing Under Hydrogel Contact Lenses , 2006, Optometry and vision science : official publication of the American Academy of Optometry.

[92]  C. Foster,et al.  Miconazole therapy for keratomycosis. , 1981, American journal of ophthalmology.

[93]  G. Kumar,et al.  NMR and molecular modelling studies on the interaction of fluconazole with β-cyclodextrin , 2009, Chemistry Central journal.

[94]  Lyndon Jones,et al.  Uptake and Release of Dexamethasone Phosphate From Silicone Hydrogel and Group I, II, and IV Hydrogel Contact Lenses , 2009, Eye & contact lens.

[95]  I. Kaur,et al.  Topical delivery of antifungal agents , 2010, Expert opinion on drug delivery.